Search results
Results from the WOW.Com Content Network
Benzamide is an organic compound with the chemical formula of C 7 H 7 NO. It is the simplest amide derivative of benzoic acid . In powdered form, it appears as a white solid, while in crystalline form, it appears as colourless crystals. [ 5 ]
Molar mass is closely related to the relative molar mass (M r) of a compound and to the standard atomic weights of its constituent elements. However, it should be distinguished from the molecular mass (which is confusingly also sometimes known as molecular weight), which is the mass of one molecule (of any single isotopic composition), and to ...
Benzamidine is a reversible competitive inhibitor of trypsin, trypsin-like enzymes, and serine proteases. [4]It is often used as a ligand in protein crystallography to prevent proteases from degrading a protein of interest.
Molar mass: 139.15 g/mol Appearance White solid Density: 1.26 g/cm 3: Melting point: ... Ammonium benzoate can be dehydrated to form benzamide. References
Sulpiride, sold under the brand name Dogmatil among others, is an atypical antipsychotic (although some texts have referred to it as a typical antipsychotic) [10] medication of the benzamide class which is used mainly in the treatment of psychosis associated with schizophrenia and major depressive disorder, and is sometimes used in low dosage to treat anxiety and mild depression.
Benzoic acid (/ b ɛ n ˈ z oʊ. ɪ k /) is a white (or colorless) solid organic compound with the formula C 6 H 5 COOH, whose structure consists of a benzene ring (C 6 H 6) with a carboxyl (−C(=O)OH) substituent.
Amisulpride is a benzamide derivative. It is structurally related to other benzamide dopamine receptor antagonists employed as antipsychotics and antiemetics including levosulpiride, metoclopramide, nemonapride, remoxipride, sulpiride, sultopride, tiapride, and veralipride.
Structurally, nemonapride is a benzamide derivative and is related to sulpiride and other benzamides. [1] Nemonapride was introduced for medical use in either 1991 [5] or 1997. [1] [6] It was developed and marketed by Yamanouchi Pharmaceuticals. [6] [7] The drug is approved only in Japan and China. [8]